通过本次交易，中国神华的煤炭保有资源量将提升至684.9亿吨，增长率达64.72%；煤炭可采储量将提升至345亿 吨，增长率达97.71%；煤炭产量将提升至5.12亿吨，增长率达56.57%；中国神华2024年每股收益将提升至3.15元/ 股，增厚6.1%。2025年1-7月每股收益提升至1.54元/股，增厚4.4%。 A股，又要见证历史了！ | | | | | | 单位: 万元 | | --- | --- | --- | --- | --- | --- | | 序号 | 交易对方 | 交易标的名称 及权益比例 | 支付方式 | | 支付总对价 | | | | | 发行股份对价 | 现金对价 | | | 1 | 国家能源集团 | 国源电力 100%股权 | 1,419,570.95 | 3.038.628.34 | 4.458.199.29 | | 2 | 国家能源集团 | 新疆能源 100%股权 | 385,968.09 | 826.174.67 | 1,212,142.76 | | ਤੇ | 国家能源集团 | 化工公司 100%股权 | 951,360.87 | 2.036.412.54 | 2.987. ...

中国神华（601088）(601088.SH)公告，公司拟通过发行A股及支付现金的方式购买国家能源集团持有的 国源电力100%股权、新疆能源100%股权、化工公司100%股权、乌海能源100%股权、平庄煤业100%股 权、神延煤炭41%股权、晋神能源49%股权、包头矿业100%股权、航运公司100%股权、煤炭运销公司 100%股权、港口公司100%股权，并以支付现金的方式购买西部能源持有的内蒙建投100%股权;同时， 上市公司拟向不超过35名特定投资者发行A股募集配套资金。调整后最终整体交易对价为1335.98亿元。 其中整体发行股份购买资产支付和现金支付比例为30%和70%。本次交易共涉及12家标的公司，业务覆 盖煤炭、坑口煤电、煤化工等多个领域，有利于提高上市公司核心业务产能与资源储备规模，进一步优 化全产业链布局，为推进清洁生产、优化产能匹配、提升盈利能力创造有利条件。 通过本次交易，中国神华的煤炭保有资源量将提升至684.9亿吨，增长率达64.72%;煤炭可采储量将提升 至345亿吨，增长率达97.71%;煤炭产量将提升至5.12亿吨，增长率达56.57%;中国神华2024年扣除非经常 性损益后的基本 ...

为进一步完善公司产业链布局，优化产品结构，增强对关键生产环节的控制与协同能力，公司拟与合肥 新站科技签署《合肥维信诺电子有限公司一致行动协议》，双方同意建立一致行动关系，合肥新站科技 成为公司的一致行动人。根据《一致行动协议》约定，合肥新站科技应在目标公司股东会的召集、提案 及表决，董事任命、分红、业务运作、日常重大事务，以及任何由股东实施或在股东会层面决策的事项 中，与公司保持一致行动，无条件且不可撤销地按公司的意见行使表决权，同时双方确认公司取得合肥 维信诺电子过半数以上的表决权和合肥维信诺电子的控制权。《一致行动协议》签署后，合肥维信诺电 子将纳入公司的合并报表范围内。 截至目前，项目公司注册资本为26.3亿元，其中合肥东欣与公司各实缴出资约11.95亿元，合肥鑫城实缴 出资约2.39亿元。近期，合肥鑫城与其全资子公司合肥新站科技产业发展集团有限公司（简称"合肥新 站科技"）签署了《合肥鑫城控股集团有限公司股权转让协议》1，其持有的项目公司9.0910%股权全额 转让至合肥新站科技，与标的股权相关的股东权利义务、债权债务在本次股权转让时一并转让。 格隆汇12月18日丨维信诺(002387.SZ)公布，公 ...

格隆汇12月18日丨维信诺(002387.SZ)公布，公司于2022年11月25日召开第六届董事会第二十四次会 议，审议通过了《关于签署 <合肥第6代柔性有源矩阵有机发光显示器件 amoled="AMOLED" 模组生产 线项目投资合作协议="模组生产线项目投资合作协议"> 的议案》，同意公司与合肥东欣投资有限公司 （简称"合肥东欣"）以及合肥鑫城国有 资产经营有限公司（曾用名，后更名为合肥鑫城控股集团有限 公司，简称"合肥鑫城"）签署《合肥第6代柔性有源矩阵有机发光显示器件（AMOLED）模组生产线项 目投资合作协议》，协议约定上述各方同意合作投资建设第6代柔性有源矩阵有机发光显示器件 （AMOLED）模组生产线项目，并同意以公司在合肥已经设立的全资子公司"合肥维信诺电子有限公 司"（简称"合肥维信诺电子"或"目标公司"）作为该生产线项目的投资、建设、运营平台。本项目投资 总额为110亿元人民币，其中项目公司注册资本55亿元，合肥东欣出资25亿元（股权占比45.4545%）， 合肥鑫城出资5亿元（股权占比9.0910%），公司出资25亿元（股权占比45.4545%），公司放弃部分优 先认缴出资权利。 截至目 ...

濮阳惠成（300481）(300481.SZ)发布公告，公司拟以现金方式收购濮阳荣安企业管理合伙企业(有限合 伙)、濮阳荣茂企业管理合伙企业(有限合伙)、濮阳荣荣企业管理合伙企业(有限合伙)持有的河南雷佰瑞 新材料科技有限公司(简称"雷佰瑞")不高于37.0051%的股权。 标的公司主营特种胺系列固化剂产品。该系列产品主要应用于风电叶片、高端装备制造、新型建筑材料 及电子工业等领域。公司产品主要应用于电气设备绝缘材料、风电叶片、有机光电材料、复合材料、涂 料、电子元器件封装材料等多个领域。本次交易与公司长远战略规划高度契合，对公司未来发展具有深 远的战略意义。通过此次收购，公司将全面优化固化剂相关产品的产业链布局，进一步巩固在风电叶片 市场的地位，同时提升产品技术含量与附加值，从而显著增强企业的核心竞争力。 ...

智通财经APP讯，濮阳惠成(300481.SZ)发布公告，公司拟以现金方式收购濮阳荣安企业管理合伙企业 (有限合伙)、濮阳荣茂企业管理合伙企业(有限合伙)、濮阳荣荣企业管理合伙企业(有限合伙)持有的河南 雷佰瑞新材料科技有限公司(简称"雷佰瑞")不高于37.0051%的股权。 标的公司主营特种胺系列固化剂产品。该系列产品主要应用于风电叶片、高端装备制造、新型建筑材料 及电子工业等领域。公司产品主要应用于电气设备绝缘材料、风电叶片、有机光电材料、复合材料、涂 料、电子元器件封装材料等多个领域。本次交易与公司长远战略规划高度契合，对公司未来发展具有深 远的战略意义。通过此次收购，公司将全面优化固化剂相关产品的产业链布局，进一步巩固在风电叶片 市场的地位，同时提升产品技术含量与附加值，从而显著增强企业的核心竞争力。 ...

雷佰瑞主营特种胺系列固化剂产品，该系列产品主要应用于风电叶片、高端装备制造、新型建筑材料及 电子工业等领域。通过此次收购，濮阳惠成将全面优化固化剂相关产品的产业链布局，进一步巩固在风 电叶片市场的地位。 人民财讯12月5日电，濮阳惠成（300481）12月5日公告，公司与河南雷佰瑞新材料科技有限公司(简 称"雷佰瑞")及其股东濮阳荣安企业管理合伙企业(有限合伙)、濮阳荣茂企业管理合伙企业(有限合伙)、 濮阳荣荣企业管理合伙企业(有限合伙)签署股权转让框架协议，公司拟以现金方式收购雷佰瑞公司不高 于37.0051%的股权，交易金额拟不超过2200万元。 ...

Core Viewpoint - Guanghetong (300638) has signed an investment agreement with the Shangli County People's Government to establish a wholly-owned subsidiary in Shangli County, Jiangxi Province, aimed at enhancing its industrial chain layout and reducing manufacturing costs [1] Group 1: Investment Details - The newly established wholly-owned subsidiary will have a registered capital of 50 million RMB [1] - The total investment in Shangli County is projected to be 400 million RMB, which includes approximately 200 million RMB for repurchasing built factory buildings and land transfer fees [1] - An additional 200 million RMB is allocated for the purchase of 10 production lines for wireless communication modules [1]

Core Viewpoint - Weigao Blood Purification (603014.SH) plans to acquire 100% equity of Weigao Purui Pharmaceutical Packaging Co., Ltd. through a share issuance, marking a significant asset restructuring and related party transaction [1] Group 1: Transaction Details - The transaction involves major stakeholders including Weigao Group Medical Polymer Products Co., Ltd., which holds 94.07% of Weigao Purui's shares, and is also the second-largest shareholder of Weigao Blood Purification [1] - The transaction is an internal asset optimization within the Weigao Group, with no change in actual control or restructuring listing implications [1] Group 2: Company Background - Weigao Purui, established in 2018 with a registered capital of 106 million yuan, is the first domestic company to obtain registration for pre-filled syringes, with products widely used in vaccines, biopharmaceuticals, and medical aesthetics [2] - Weigao Blood Purification is experiencing steady growth, reporting total revenue of 2.736 billion yuan in the first three quarters of this year, a year-on-year increase of 3.45%, and a net profit of 341 million yuan, up 7.92% [2] Group 3: Strategic Implications - The acquisition is a key step for Weigao Blood Purification to enhance its industry chain layout, allowing for product line expansion into pharmaceutical packaging [3] - The integration aims to leverage Weigao Blood Purification's hollow fiber filtration technology and Weigao Purui's customer resources in biopharmaceuticals, facilitating mutual empowerment in the biopharmaceutical filter business [3] - This restructuring is part of Weigao Group's resource optimization strategy, which already includes four listed companies across various medical fields [3]

Core Viewpoint - China Shenhua has announced a transaction plan to acquire assets from its controlling shareholder, China Energy Investment Corporation, involving 13 target companies across coal, pit coal power, and coal chemical industries [2][6]. Group 1: Transaction Details - The transaction involves a total asset value of 258.36 billion yuan and a net asset value of 93.89 billion yuan for the target assets by the end of 2024 [2]. - The total expected operating revenue for the target assets in 2024 is 125.996 billion yuan, with a net profit of 8.005 billion yuan after deducting non-recurring gains and losses [2]. - The acquisition will be executed through a combination of issuing shares and cash payments, with the share price set at 30.38 yuan per share, compared to a trading price of 37.56 yuan at the time of suspension [4]. Group 2: Business Overlap and Integration - The acquisition aims to resolve substantial business overlaps between China Shenhua and its controlling shareholder in coal, pit coal power, coal chemical, and logistics sectors [6]. - The transaction will enhance the asset scale and profitability of China Shenhua, integrating multiple core quality assets [6]. Group 3: Financial Performance of Target Companies - Among the 13 target companies, Guoyuan Power is expected to achieve a net profit of 2.791 billion yuan in 2024, leading in profitability [6][7]. - Other notable expected net profits for 2024 include: Shenyuan Coal at 2.552 billion yuan, Wuhai Energy at 1.524 billion yuan, Xinjiang Energy at 0.761 billion yuan, and the Chemical Company at 0.669 billion yuan [7]. Group 4: Resource and Capacity Enhancement - The acquisition will significantly increase resource reserves and core business capacity, with Xinjiang Energy's coal mine having a certified production capacity of 35 million tons per year, making it the second-largest open-pit coal mine in China [9]. - The strategic layout of the acquired companies will complement existing coal resources geographically, enhancing logistics capabilities and supporting a modern coal supply system [9][10]. Group 5: Profit Distribution Plan - China Shenhua plans to distribute at least 75% of its net profit attributable to shareholders for the first half of 2025, with an expected net profit range of 23.6 billion to 25.6 billion yuan [12].